globenewswire.com · Nov 18, 2025
Curative Biotechnology, Inc. Announces Letter to Shareholders
Strategic Update and New Path to Value Creation Palm Beach Gardens, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases, today announced the following update to shareholders. Dear fellow shareholders and interested investors, We are writing to provide an important update on our business strategy and operational path forward.
